Physician profile
Kevin E Till
NPI 1467522110
$1,222.88
in general payments reported to CMS, 2019-2025
17 companies · $85.81 in 2025
The $85.81 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $140 · 2021: $17.47 · 2022: $255 · 2023: $202 · 2024: $15.73 · 2025: $85.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $254.34 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $145.30 | 2019-2022 | |
| Osiris Therapeutics INC. | $128.78 | 2019 | |
| Cardiovascular Systems INC. | $108.35 | 2020 | |
| Avinger INC. | $98.60 | 2019 | |
| Kerecis Limited | $85.81 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Arthrosurface Incorporated | $75.02 | 2019 | |
| Paragon 28, INC. | $58.24 | 2019 | |
| Treace Medical Concepts, INC. | $56.86 | 2023 | |
| Polynovo North America LLC | $53.33 | 2022 | |
| Osteomed LLC | $35.47 | 2020-2022 | |
| Access Pro Medical, LLC | $35.46 | 2023 | Matriderm |
| Averitas Pharma INC. | $23.28 | 2023 | Qutenza |
| Acell, INC. | $19.03 | 2019 | |
| Mimedx Group, INC. | $15.73 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.34 | 2019 | |
| Hartmann USA, INC. | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Till listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.